← Back to Aster DM Healthcare Ltd. overview
Aster DM Healthcare Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹4,069 cr | ₹5,378 cr | ₹107.85 | ₹6,606 cr | ₹3,428 cr | 156.88% | 10.63% | 0.59x | 132.15% |
| FY2024 | ₹3,638 cr | ₹129 cr | ₹2.6 | ₹17,991 cr | ₹4,560 cr | 2.84% | 6.18% | 0.3x | 3.55% |
| FY2023 | ₹2,952 cr | ₹425 cr | ₹8.53 | ₹14,881 cr | ₹4,448 cr | 9.55% | 2.77% | 1.28x | 14.39% |
| FY2022 | ₹10,253 cr | ₹526 cr | ₹10.57 | ₹12,546 cr | ₹3,953 cr | 13.3% | 10.09% | 1.24x | 5.13% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.